InvestorsHub Logo
icon url

Jack Torrance

11/03/21 9:37 PM

#132076 RE: redwing992006 #132072

Two separate things, dude. Do a little DD.
icon url

Mutat

11/03/21 10:22 PM

#132077 RE: redwing992006 #132072

Look this up and maybe it will answer your question about one product. The mAbs are on another level all by themselves. https://enzoimmune.com/
icon url

foxi

11/04/21 2:05 AM

#132084 RE: redwing992006 #132072

Afaik Enzoimmune Active (ITV-1 which uses IPF) binds to the covid spike protein and blocks viral infection. It's a preventative but possibly a highly effective one. Clone 3 (monoclonal antibodies) bind to the gp41 target site on covid (the 'core' part of the virus) and possibly also to the spike protein just like IPF, blocking viral infection and acting more as a permanent "cure"

More about IPF on page 21
https://sec.report/otc/financial-report/123399

Both products increase white blood cell count and mutate white blood cells to be resistant to HIV and covid. Sounds good on paper, though it's monkeying with the body's natural immune function, so like mRNA there's some longer term question marks relating to unintended side effects. Will seem "safer" than mRNA gene therapy to some people. Effective HIV and covid treatments of any type are in great demand.